Evidence map›Paper›PMID 32440559›Full record

ArticleBioengineering & translational medicine2020

Targeting functionalized nanoparticles to activated endothelial cells under high wall shear stress.

Hila Zukerman, Maria Khoury, Yosi Shammay, Josué Sznitman, Noah Lotan, Netanel Korin

Open access · goldAbstract read
In one paragraph

Article in Bioengineering & translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Multiscale physics-basedFrontiers in drug delivery · 2024
    Review
  9. Article
  10. Advances in nanomaterial-based targeted drug delivery systems.Frontiers in bioengineering and biotechnology · 2023
    Review
  11. Review
  12. Review
  13. Biophysical targeting of high-risk cerebral aneurysms.Bioengineering & translational medicine · 2022
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hila ZukermanDepartment of Biomedical Engineering Technion - Israel Institute of Technology Haifa Israel.
Maria KhouryDepartment of Biomedical Engineering Technion - Israel Institute of Technology Haifa Israel.
Yosi ShammayDepartment of Biomedical Engineering Technion - Israel Institute of Technology Haifa Israel.
Josué SznitmanDepartment of Biomedical Engineering Technion - Israel Institute of Technology Haifa Israel.ORCID https://orcid.org/0000-0001-8217-3842
Noah LotanDepartment of Biomedical Engineering Technion - Israel Institute of Technology Haifa Israel.
Netanel KorinDepartment of Biomedical Engineering Technion - Israel Institute of Technology Haifa Israel.ORCID https://orcid.org/0000-0001-7244-889X
Technion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Local inflammation of the endothelium is associated with a plethora of cardiovascular diseases. Vascular-targeted carriers (VTCs) have been advocated to provide focal effective therapeutics to these disease sites. Here, we examine the design of functionalized nanoparticles (NPs) as VTCs that can specifically localize at an inflamed vessel wall under pathological levels of high shear stress, associated for example with clinical (or in vivo) conditions of vascular narrowing and arteriogenesis. To test this, carboxylated fluorescent 200 nm polystyrene particles were functionalized with ligands to activated endothelium, that is, an E-selectin binding peptide (Esbp), an anti ICAM-1 antibody, or using a combination of both. The functionalized NPs were investigated in vitro using microfluidic models lined with inflamed (TNF-α stimulated) and control endothelial cells (EC). Specifically, their adhesion was monitored under different relevant wall shear stresses (i.e., 40-300 dyne/cm

Indexed as

drug deliveryendotheliuminflammationmicrofluidicsshear stressvascular‐targeted carriers (VTCs)

Identifiers

PMID32440559
PMCPMC7237145
OpenAlexW2994058456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.